BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma C, Liu Y, Neumann S, Gao X. Nicotine from cigarette smoking and diet and Parkinson disease: a review. Transl Neurodegener 2017;6:18. [PMID: 28680589 DOI: 10.1186/s40035-017-0090-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 9.2] [Reference Citation Analysis]
Number Citing Articles
1 Xu S, Yang B, Tao T, Zhang J, Liu Y, Hu J, Fan Y, Zhang G. Activation of α7-nAChRs protects SH-SY5Y cells from 1-methyl-4-phenylpyridinium-induced apoptotic cell death via ERK/p53 signaling pathway. J Cell Physiol 2019;234:18480-91. [PMID: 30912145 DOI: 10.1002/jcp.28484] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
2 Chandler RJ, Cogo S, Lewis PA, Kevei E. Modelling the functional genomics of Parkinson's disease in Caenorhabditis elegans: LRRK2 and beyond. Biosci Rep 2021;41:BSR20203672. [PMID: 34397087 DOI: 10.1042/BSR20203672] [Reference Citation Analysis]
3 Franco R, Rivas-Santisteban R, Reyes-Resina I, Navarro G, Martínez-Pinilla E. Microbiota and Other Preventive Strategies and Non-genetic Risk Factors in Parkinson's Disease. Front Aging Neurosci 2020;12:12. [PMID: 32226375 DOI: 10.3389/fnagi.2020.00012] [Reference Citation Analysis]
4 Ozkizilcik A, Sharma A, Lafuente JV, Muresanu DF, Castellani RJ, Nozari A, Tian ZR, Mössler H, Sharma HS. Nanodelivery of cerebrolysin reduces pathophysiology of Parkinson's disease. Nanoneuroprotection and Nanoneurotoxicology. Elsevier; 2019. pp. 201-46. [DOI: 10.1016/bs.pbr.2019.03.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
5 Alhowail A. Molecular insights into the benefits of nicotine on memory and cognition (Review). Mol Med Rep 2021;23:398. [PMID: 33786606 DOI: 10.3892/mmr.2021.12037] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Li Q, Wang C, Tang H, Chen S, Ma J. Stroke and Coronary Artery Disease Are Associated With Parkinson’s Disease. Can J Neurol Sci 2018;45:559-65. [DOI: 10.1017/cjn.2018.56] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Bono F, Mutti V, Savoia P, Barbon A, Bellucci A, Missale C, Fiorentini C. Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer. Neurobiol Dis 2019;129:1-12. [PMID: 31051233 DOI: 10.1016/j.nbd.2019.04.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
8 Giannakis A, Chondrogiorgi M, Tsironis C, Tatsioni A, Konitsiotis S. Levodopa-induced dyskinesia in Parkinson's disease: still no proof? A meta-analysis. J Neural Transm (Vienna) 2018;125:1341-9. [PMID: 29352351 DOI: 10.1007/s00702-018-1841-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Alghamdi BS. The neuroprotective role of melatonin in neurological disorders. J Neurosci Res 2018;96:1136-49. [PMID: 29498103 DOI: 10.1002/jnr.24220] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 15.3] [Reference Citation Analysis]
10 van Hout M, Klein J, Ahring PK, Brown DT, Thaneshwaran S, Dos Santos AB, Jensen AA, Kohlmeier KA, Christophersen P, Dyhring T. Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptors. Biochem Pharmacol 2020;174:113788. [PMID: 31887290 DOI: 10.1016/j.bcp.2019.113788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Bono F, Mutti V, Fiorentini C, Missale C. Dopamine D3 Receptor Heteromerization: Implications for Neuroplasticity and Neuroprotection. Biomolecules 2020;10:E1016. [PMID: 32659920 DOI: 10.3390/biom10071016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
12 Rencus-Lazar S, DeRowe Y, Adsi H, Gazit E, Laor D. Yeast Models for the Study of Amyloid-Associated Disorders and Development of Future Therapy. Front Mol Biosci 2019;6:15. [PMID: 30968029 DOI: 10.3389/fmolb.2019.00015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
13 Longhena F, Faustini G, Brembati V, Pizzi M, Bellucci A. The good and bad of therapeutic strategies that directly target α-synuclein. IUBMB Life 2020;72:590-600. [PMID: 31693290 DOI: 10.1002/iub.2194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
14 Gątarek P, Kałużna-Czaplińska J. Nutritional aspects in Parkinson's disease. Crit Rev Food Sci Nutr 2021;:1-18. [PMID: 33749400 DOI: 10.1080/10408398.2021.1902261] [Reference Citation Analysis]
15 Panchal K, Tiwari AK. Mitochondrial dynamics, a key executioner in neurodegenerative diseases. Mitochondrion. 2019;47:151-173. [PMID: 30408594 DOI: 10.1016/j.mito.2018.11.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 12.0] [Reference Citation Analysis]
16 Agliardi C, Guerini FR, Zanzottera M, Riboldazzi G, Zangaglia R, Sturchio A, Casali C, Di Lorenzo C, Minafra B, Nemni R, Clerici M. SNAP25 Gene Polymorphisms Protect Against Parkinson's Disease and Modulate Disease Severity in Patients. Mol Neurobiol 2019;56:4455-63. [PMID: 30334187 DOI: 10.1007/s12035-018-1386-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
17 Wei Y, Lv Y, Zhou J, Gao X, Duan J, Zhao C, Yin Z, Kang Q, Wu B, Chen C, Mao C, Li J, Shi X. Smoking cessation in late life is associated with increased risk of all-cause mortality amongst oldest old people: a community-based prospective cohort study. Age Ageing 2021;50:1298-305. [PMID: 33492360 DOI: 10.1093/ageing/afaa280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Schneider Medeiros M, P Reddy S, P Socal M, Schumacher-Schuh AF, Mello Rieder CR. Occupational pesticide exposure and the risk of death in patients with Parkinson's disease: an observational study in southern Brazil. Environ Health 2020;19:68. [PMID: 32552814 DOI: 10.1186/s12940-020-00624-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Kavitha RV, Kumar J, Egbuna C, Ifemeje JC. Phytochemicals as therapeutic interventions in neurodegenerative diseases. Phytochemicals as Lead Compounds for New Drug Discovery. Elsevier; 2020. pp. 161-78. [DOI: 10.1016/b978-0-12-817890-4.00010-x] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
20 Wändell P, Fredrikson S, Carlsson AC, Li X, Sundquist J, Sundquist K. Parkinson's Disease Among Immigrant Groups and Swedish-Born Individuals: A Cohort Study of All Adults 50 Years of Age and Older in Sweden. J Parkinsons Dis 2020;10:1133-41. [PMID: 32568106 DOI: 10.3233/JPD-201962] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Elgayar SAM, Hussein OA, Mubarak HA, Ismaiel AM, Gomaa AMS. Testing efficacy of the nicotine protection of the substantia nigra pars compacta in a rat Parkinson disease model. Ultrastructure study. Ultrastruct Pathol 2022;:1-17. [PMID: 35001795 DOI: 10.1080/01913123.2021.2015499] [Reference Citation Analysis]
22 Pirooznia SK, Rosenthal LS, Dawson VL, Dawson TM. Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection. Pharmacol Rev 2021;73:33-97. [PMID: 34663684 DOI: 10.1124/pharmrev.120.000189] [Reference Citation Analysis]
23 Zeng Z, Roussakis AA, Lao-Kaim NP, Piccini P. Astrocytes in Parkinson's disease: from preclinical assays to in vivo imaging and therapeutic probes. Neurobiol Aging 2020;95:264-70. [PMID: 32905922 DOI: 10.1016/j.neurobiolaging.2020.07.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Koren G, Norton G, Radinsky K, Shalev V. Chronic Use of β-Blockers and the Risk of Parkinson's Disease. Clin Drug Investig 2019;39:463-8. [PMID: 30868473 DOI: 10.1007/s40261-019-00771-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
25 Boulos C, Yaghi N, El Hayeck R, Heraoui GN, Fakhoury-Sayegh N. Nutritional Risk Factors, Microbiota and Parkinson's Disease: What Is the Current Evidence? Nutrients 2019;11:E1896. [PMID: 31416163 DOI: 10.3390/nu11081896] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
26 Mamoshina P, Kochetov K, Cortese F, Kovalchuk A, Aliper A, Putin E, Scheibye-Knudsen M, Cantor CR, Skjodt NM, Kovalchuk O, Zhavoronkov A. Blood Biochemistry Analysis to Detect Smoking Status and Quantify Accelerated Aging in Smokers. Sci Rep 2019;9:142. [PMID: 30644411 DOI: 10.1038/s41598-018-35704-w] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
27 Fernandez-Abascal J, Chiaino E, Frosini M, Davey GP, Valoti M. β-Naphthoflavone and Ethanol Reverse Mitochondrial Dysfunction in A Parkinsonian Model of Neurodegeneration. Int J Mol Sci 2020;21:E3955. [PMID: 32486438 DOI: 10.3390/ijms21113955] [Reference Citation Analysis]
28 Fink J, Pathak H, Smith J, Achat-Mendes C, Haining RL. Development of a Competition-Binding Assay to Determine Binding Affinity of Molecules to Neuromelanin via Fluorescence Spectroscopy. Biomolecules 2019;9:E175. [PMID: 31072013 DOI: 10.3390/biom9050175] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
29 Hassan Q, Li S, Ferrag C, Kerman K. Electrochemical biosensors for the detection and study of α-synuclein related to Parkinson's disease - A review. Anal Chim Acta 2019;1089:32-9. [PMID: 31627816 DOI: 10.1016/j.aca.2019.09.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
30 Nourse JB Jr, Harshefi G, Marom A, Karmi A, Cohen Ben-Ami H, Caldwell KA, Caldwell GA, Treinin M. Conserved nicotine-activated neuroprotective pathways involve mitochondrial stress. iScience 2021;24:102140. [PMID: 33665559 DOI: 10.1016/j.isci.2021.102140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Choi HG, Lim JS, Lee YK, Sim S, Kim M. Mortality and cause of death in South Korean patients with Parkinson's disease: a longitudinal follow-up study using a national sample cohort. BMJ Open 2019;9:e029776. [PMID: 31530603 DOI: 10.1136/bmjopen-2019-029776] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
32 Cheng Y, Wang Y. Tobacco smoking and the reduced risk of Parkinson disease: A puzzle of 60 years. Neurology 2020;94:860-1. [DOI: 10.1212/wnl.0000000000009431] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
33 Carvajal-Oliveros A, Domínguez-Baleón C, Zárate RV, Campusano JM, Narváez-Padilla V, Reynaud E. Nicotine suppresses Parkinson's disease like phenotypes induced by Synphilin-1 overexpression in Drosophila melanogaster by increasing tyrosine hydroxylase and dopamine levels. Sci Rep 2021;11:9579. [PMID: 33953275 DOI: 10.1038/s41598-021-88910-4] [Reference Citation Analysis]
34 Su TH, Yang HC, Tseng TC, Chou SW, Lin CH, Liu CH, Liu CJ, Chen CL, Kao JH. Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism. Mov Disord 2019;34:1882-90. [PMID: 31505068 DOI: 10.1002/mds.27848] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
35 Seddighi S, Houck AL, Rowe JB, Pharoah PDP. Evidence of a Causal Association Between Cancer and Alzheimer's Disease: a Mendelian Randomization Analysis. Sci Rep 2019;9:13548. [PMID: 31537833 DOI: 10.1038/s41598-019-49795-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
36 Zhao J, Park S, Kim JW, Qi J, Zhou Z, Lim CW, Kim B. Nicotine attenuates concanavalin A-induced liver injury in mice by regulating the α7-nicotinic acetylcholine receptor in Kupffer cells. Int Immunopharmacol 2020;78:106071. [PMID: 31835083 DOI: 10.1016/j.intimp.2019.106071] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
37 Zarate SM, Pandey G, Chilukuri S, Garcia JA, Cude B, Storey S, Salem NA, Bancroft EA, Hook M, Srinivasan R. Cytisine is neuroprotective in female but not male 6-hydroxydopamine lesioned parkinsonian mice and acts in combination with 17-β-estradiol to inhibit apoptotic endoplasmic reticulum stress in dopaminergic neurons. J Neurochem 2021;157:710-26. [PMID: 33354763 DOI: 10.1111/jnc.15282] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
38 Ma C, Molsberry S, Li Y, Schwarzschild M, Ascherio A, Gao X. Dietary nicotine intake and risk of Parkinson disease: a prospective study. Am J Clin Nutr 2020;112:1080-7. [PMID: 32725131 DOI: 10.1093/ajcn/nqaa186] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Devi K, Moharana B. Cigarette smoke extract triggers neoplastic change in lungs and impairs locomotor activity through wnt3a-β-catenin signaling in aged COPD rodent model. Exp Lung Res 2020;46:283-96. [PMID: 32729343 DOI: 10.1080/01902148.2020.1800139] [Reference Citation Analysis]